CG
EXAS

Cynosure Group’s Exact Sciences EXAS Stock Holding History

Cynosure Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,314
Closed -$743K – 292
2025
Q4 		$743K Buy
+7,314
New +$587K 0.08% 92

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Cynosure Group's EXAS Position: Q1 2026 in Review

Cynosure Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 7,314 shares — an estimated $743K sold.

Cynosure Group first reported a position in EXAS in Q4 2025 and held it in 1 quarter. The position peaked at $743K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Cynosure Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Cynosure Group sold 7,314 Exact Sciences shares in Q1 2026, an estimated $743K.
  • Cynosure Group first reported a position in Exact Sciences in Q4 2025 and held it in 1 quarter.
  • Cynosure Group's Exact Sciences position peaked at $743K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.